VBI Vaccines Inc (VBIV)
0.8614
0.00 (0.00%)
USD |
NASDAQ |
May 27, 09:36
VBI Vaccines Gross Profit Margin (Quarterly): -2.09K% for March 31, 2022
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -2.09K% |
| December 31, 2021 | -3.92K% |
| September 30, 2021 | -2.20K% |
| June 30, 2021 | -1.75K% |
| March 31, 2021 | -701.3% |
| December 31, 2020 | -1.38K% |
| September 30, 2020 | -608.4% |
| June 30, 2020 | -1.02K% |
| March 31, 2020 | -521.0% |
| December 31, 2019 | -350.3% |
| September 30, 2019 | -205.6% |
| June 30, 2019 | -267.8% |
| March 31, 2019 | -227.5% |
| December 31, 2018 | 54.25% |
| Date | Value |
|---|---|
| September 30, 2018 | -209.3% |
| June 30, 2018 | -356.0% |
| March 31, 2018 | -693.8% |
| December 31, 2017 | -510.4% |
| September 30, 2017 | -591.2% |
| June 30, 2017 | -294.5% |
| March 31, 2017 | -903.9% |
| December 31, 2016 | -695.6% |
| September 30, 2016 | -434.2% |
| June 30, 2016 | -757.3% |
| March 31, 2016 | -685.4% |
| December 31, 2015 | |
| September 30, 2015 | -742.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-3.92K%
Minimum
Dec 2021
54.25%
Maximum
Dec 2018
-892.4%
Average
-556.1%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Voyager Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 57.66% |
| Palatin Technologies Inc | 78.29% |
| iBio Inc | 97.53% |
| Synthetic Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -46.92% |
| Return on Assets | -34.09% |
| Return on Invested Capital | -40.26% |
| Profit Margin (Quarterly) | -16.87K% |
| Operating Margin (Quarterly) | -12.63K% |
| Return on Net Operating Assets | -65.75% |